: Clostridium perfringens enterotoxin (CPE) is responsible for the gastrointestinal (Gl) symptoms of C. perfringens type A food poisoning, the 3rd most common foodborne illness in the USA, as well as certain nonfoodborne human Gl diseases. The long-term objective of this project is to identify strategies to prevent or control CPE-associated Gl disease by understanding the pathogenesis of these illness via a focus on CPE's unique mechanism of action. To progress towards this goal, the next grant period will pursue the following aims: 1) further evaluating CPE interactions with claudin receptors by Western blotting electroeluted proteins from CPE complexes, using claudin-1 or -4 transfectants to distinguish whether CPE interacts with claudins from the same or apposing claudin fibrils, using site-directed mutagenesis to identify specific claudin regions/amino acids that bind CPE, and evaluating by immunohistochemistry/SDS-PAGE whether CPE interacts with claudins in vivo, 2) continued analysis of post-binding steps in CPE action by mass spectroscopy analyses of proteins in CPE complexes, determining via SDS-PAGE how many CPE proteins are present in each complex, testing for CPE internalization into host cells by immunofluorescent microscopy, and conducting Western blot/ELISA evaluations of the contribution of lipid rafts, activated calpain, or inflammation to CPE action in vivo and in vitro, 3) additional study of the CPE structure function relationship using site-directed mutagenesis/fluorescent spectroscopy techniques to identify specific CPE amino acids involved in receptor binding and CPE insertion into membranes, and x-ray diffraction to determine the 3-D structure of the CPE protein, and 4) further analyzing the molecular pathogenesis of CPE-positive C. perfringens type A isolates by using PCR, microarrays and Southern blots to study the diversity of the cpe plasmid and by evaluating the contribution of beta2 toxin to the pathogenesis of CPE-associated nonfoodborne Gl disease by constructing isogenic beta2 toxin mutants.
| Rood, Julian I; Adams, Vicki; Lacey, Jake et al. (2018) Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe : |
| Shrestha, Archana; Hendricks, Matthew R; Bomberger, Jennifer M et al. (2016) Bystander Host Cell Killing Effects of Clostridium perfringens Enterotoxin. MBio 7: |
| Shrestha, Archana; Uzal, Francisco A; McClane, Bruce A (2016) The interaction of Clostridium perfringens enterotoxin with receptor claudins. Anaerobe 41:18-26 |
| Li, Jihong; Paredes-Sabja, Daniel; Sarker, Mahfuzur R et al. (2016) Clostridium perfringens Sporulation and Sporulation-Associated Toxin Production. Microbiol Spectr 4: |
| Uzal, Francisco A; McClane, Bruce A; Cheung, Jackie K et al. (2015) Animal models to study the pathogenesis of human and animal Clostridium perfringens infections. Vet Microbiol 179:23-33 |
| Freedman, John C; Theoret, James R; Wisniewski, Jessica A et al. (2015) Clostridium perfringens type A-E toxin plasmids. Res Microbiol 166:264-79 |
| Yelland, Tamas S; Naylor, Claire E; Bagoban, Tannya et al. (2014) Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2. J Mol Biol 426:3134-3147 |
| Uzal, Francisco A; Freedman, John C; Shrestha, Archana et al. (2014) Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol 9:361-77 |
| Adams, Vicki; Li, Jihong; Wisniewski, Jessica A et al. (2014) Virulence Plasmids of Spore-Forming Bacteria. Microbiol Spectr 2: |
| Li, Jihong; McClane, Bruce A (2014) Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease. Infect Immun 82:4620-30 |
Showing the most recent 10 out of 97 publications
